Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Edge Rankings
Stock Score Locked: Edge Members Only
Benzinga Rankings give you vital metrics on any stock – anytime.
OncoCyte Stock Price, Quotes and Forecasts | NASDAQ:OCX | Benzinga
Explore OncoCyte stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OCX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy OncoCyte (OCX) stock?
You can purchase shares of OncoCyte (NASDAQ:OCX) through any online brokerage.
Who are OncoCyte (OCX) competitors?
Other companies in OncoCyte’s space includes: Macrogenics (NASDAQ:MGNX), Cabaletta Bio (NASDAQ:CABA), Zentalis Pharma (NASDAQ:ZNTL), Atossa Therapeutics (NASDAQ:ATOS) and Sangamo Therapeutics (NASDAQ:SGMO).
What is the forecast, or price target, for OncoCyte (OCX) stock?
OncoCyte has a consensus price target of $4.85.
What is the current price for OncoCyte (OCX)?
The stock price for OncoCyte (NASDAQ: OCX) is $3.27 last updated May 29, 2025 at 2:47 PM EDT.
Does OncoCyte (OCX) pay a dividend?
There are no upcoming dividends for OncoCyte.
When is OncoCyte (NASDAQ:OCX) reporting earnings?
OncoCyte’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is OncoCyte (OCX) going to split?
There is no upcoming split for OncoCyte.
What sector and industry does OncoCyte (OCX) operate in?
OncoCyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
